Drug Trial Radar · NCT03932864
Study Assessing Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MGTA-145 in Healthy Volunteers as a Single Agent or in Combination With Plerixafor
Last checked: Nov 20, 2026Latest source record: Jan 11, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
107
Actual
Start
Apr 22, 2019
Primary completion
Feb 25, 2020
Study completion Feb 25, 2020
Sponsor
- Lead sponsor
- EnsomaIndustry
- Sponsor type
- Industry
- First posted
- May 1, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 60 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of MGTA-145 in healthy volunteers as a single agent and in combination with plerixafor.
Conditions
- Healthy Volunteers
Interventions
MGTA-145Biological
MGTA-145 will be given in various doses intravenously
plerixaforBiological
240 µg/kg subcutaneously
PlaceboBiological
Placebo will be given in various doses intravenously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety as measured by incidence of treatment-emergent adverse events (AEs), serious adverse events (SAEs), and dose-limiting toxicities (DLTs).Time frame: 28 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Medpace CPU
Cincinnati, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.